Home » Stocks » SIBN

SI-BONE, Inc. (SIBN)

Stock Price: $32.26 USD -0.27 (-0.83%)
Updated May 6, 2021 4:00 PM EDT - Market closed
Market Cap 1.07B
Revenue (ttm) 77.01M
Net Income (ttm) -43.17M
Shares Out 32.69M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $32.26
Previous Close $32.53
Change ($) -0.27
Change (%) -0.83%
Day's Open 32.27
Day's Range 31.46 - 32.64
Day's Volume 301,709
52-Week Range 14.40 - 37.21

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Si-Bone (SIBN) delivered earnings and revenue surprises of 2.63% and 7.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 days ago - Zacks Investment Research

Shares of SI-BONE (NASDAQ:SIBN) remained quited after the company reported Q1 results. Quarterly Results Earnings per share were up 21.28% year over year to ($0.37), which beat the estimate of ($0.39).

3 days ago - Benzinga

SANTA CLARA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fina...

3 days ago - GlobeNewsWire

SANTA CLARA, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

2 weeks ago - GlobeNewsWire

SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ana...

2 weeks ago - GlobeNewsWire

SANTA CLARA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced ...

3 weeks ago - GlobeNewsWire

Si-Bone (SIBN) delivered earnings and revenue surprises of 6.67% and 0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 22.22% year over year to ($0.28), which beat the estima...

1 month ago - Benzinga

SANTA CLARA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fi...

1 month ago - GlobeNewsWire

SI-BONE (NASDAQ:SIBN) releases its next round of earnings this Monday, March 08. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.

2 months ago - Benzinga

SANTA CLARA, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced i...

2 months ago - GlobeNewsWire

Laura Francis to Become Chief Executive Officer; Jeff Dunn to Become Executive Chairman;  and Tony Recupero to Become President.

3 months ago - GlobeNewsWire

Updated Blue Cross Blue Shield Association Evidence Rating Supports only Triangular Implants Updated Blue Cross Blue Shield Association Evidence Rating Supports only Triangular Implants

4 months ago - GlobeNewsWire

SANTA CLARA, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced t...

4 months ago - GlobeNewsWire

Humana is one of the 5 largest commercial payors in the U.S. and joins 36 other commercial health plans that offer coverage for the triangular iFuse Implant System only Humana is one of the 5 largest co...

4 months ago - GlobeNewsWire

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

SANTA CLARA, Calif. , Nov. 02, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fi...

6 months ago - GlobeNewsWire

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

SANTA CLARA, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced i...

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices used in t...

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company focused on the development of implantable devices used in t...

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced pr...

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anat...

7 months ago - GlobeNewsWire

SANTA CLARA, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced toda...

8 months ago - GlobeNewsWire

SANTA CLARA, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce...

8 months ago - GlobeNewsWire

SI-BONE is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

8 months ago - Zacks Investment Research

35 U.S. payers now cover iFuse exclusively 35 U.S. payers now cover iFuse exclusively

8 months ago - GlobeNewsWire

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Si-Bone (SIBN) delivered earnings and revenue surprises of 31.25% and 48.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

SANTA CLARA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported f...

9 months ago - GlobeNewsWire

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

9 months ago - GlobeNewsWire

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

SANTA CLARA, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

9 months ago - GlobeNewsWire

SANTA CLARA, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic an...

11 months ago - GlobeNewsWire

New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction

11 months ago - GlobeNewsWire

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Si-Bone (SIBN) delivered earnings and revenue surprises of -30.56% and -6.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

SANTA CLARA, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fi...

1 year ago - GlobeNewsWire

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

New positive coverage policy is specific for FDA cleared implants placed across the SI joint and intended to promote bone fusion New positive coverage policy is specific for FDA cleared implants placed ...

1 year ago - GlobeNewsWire

SANTA CLARA, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic an...

1 year ago - GlobeNewsWire

SI-BONE, Inc.'s (SIBN) CEO Jeff Dunn on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Long-term follow-up results show excellent durability of clinical responses and positive radiographic outcomes for SI joint fusion using triangular titanium implants Long-term follow-up results show exc...

1 year ago - GlobeNewsWire

SANTA CLARA, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...

1 year ago - GlobeNewsWire

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

SI-BONE's (SIBN) CEO Jeff Dunn on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Industry
Medical Devices
IPO Date
Oct 17, 2018
CEO
Jeffrey Dunn
Employees
295
Stock Exchange
NASDAQ
Ticker Symbol
SIBN
Full Company Profile

Financial Performance

In 2020, SI-BONE, Inc.'s revenue was $73.39 million, an increase of 9.04% compared to the previous year's $67.30 million. Losses were -$43.70 million, 13.8% more than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for SI-BONE, Inc. stock is "Strong Buy." The 12-month stock price forecast is 41.29, which is an increase of 27.99% from the latest price.

Price Target
$41.29
(27.99% upside)
Analyst Consensus: Strong Buy